Michael S. Wyzga

CIK: 0001201256

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

TVRD

Tvardi Therapeutics, Inc.

Director

MREO

Mereo BioPharma Group plc

Director

XFOR

X4 Pharmaceuticals, Inc

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

TVRD
Tvardi Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (right to buy)
Direct
6K shares-
MREO
Mereo BioPharma Group plc
Feb 26, 2026
Award(A)
Share Options (Right to buy)
Direct
66K shares-
XFOR
X4 Pharmaceuticals, Inc
Jan 1, 2026
Award(A)
Stock Option (right to buy)
Direct
110K shares-
XFOR
X4 Pharmaceuticals, Inc
Jun 9, 2025
Award(A)
Direct
1.5K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 17, 2025
Award(A)
Stock Option (right to buy)
Direct
12K shares-
TVRD
Tvardi Therapeutics, Inc.
Apr 15, 2025
Award(A)
Stock Option (right to buy)
Direct
18.4K shares-
MREO
Mereo BioPharma Group plc
Feb 5, 2025
Award(A)
Deferred Restricted Stock Units
Direct
30.5K shares-
MREO
Mereo BioPharma Group plc
Feb 5, 2025
Award(A)
Share Options (Right to buy)
Direct
55K shares-

		Type	Shares	Price		Ownership
Jun 9, 2026	TVRD Tvardi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	6,000	-	-	Direct
Feb 26, 2026	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	66,000	-	-	Direct
Jan 1, 2026	XFOR X4 Pharmaceuticals, Inc	Award(A) Stock Option (right to buy)	110,000	-	-	Direct
Jun 9, 2025	XFOR X4 Pharmaceuticals, Inc	Award(A)	1,500	-	-	Direct
Apr 17, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	12,000	-	-	Direct
Apr 15, 2025	TVRD Tvardi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	18,441	-	-	Direct
Feb 5, 2025	MREO Mereo BioPharma Group plc	Award(A) Deferred Restricted Stock Units	30,487	-	-	Direct
Feb 5, 2025	MREO Mereo BioPharma Group plc	Award(A) Share Options (Right to buy)	55,000	-	-	Direct

1-8 of 8 transactions

About WYZGA MICHAEL S

WYZGA MICHAEL S (SEC CIK 0001201256) files insider reports with the SEC as Director of Tvardi Therapeutics, Inc. (TVRD), Director of Mereo BioPharma Group plc (MREO) and Director of X4 Pharmaceuticals, Inc (XFOR).

Signal8 holds 8 ownership filings by WYZGA MICHAEL S (1 Form 3, 7 Form 4), filed between Feb 6, 2025 and Jun 11, 2026. Those filings report 8 transactions, from Feb 5, 2025 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WYZGA MICHAEL S's filings is in SUGAR LAND, TX.

Recent filings by WYZGA MICHAEL S

Jun 9, 2026: Grant or award of TVRD derivative securities (Form 4, code A).
Feb 26, 2026: Grant or award of MREO derivative securities (Form 4, code A).
Jan 1, 2026: Grant or award of XFOR derivative securities (Form 4, code A).
Jun 9, 2025: Grant or award of XFOR shares (Form 4, code A).
Apr 17, 2025: Grant or award of TVRD derivative securities (Form 4, code A).

Other insiders filing for Tvardi Therapeutics, Inc. (TVRD)

Shiff Susan Ph.D., Director
Smith Cynthia, Director
Shah Sujal, Director
HALL WALLACE L JR, Director
O'Brien Stephen Paul, Principal Accounting Officer
Conn Avi Daniel, Chief Financial Officer

How to read Form 4 transaction codes